Effect of Sulodexide in Overt Diabetic Nephropathy

Clinical trial NCT00130312 · TERMINATED

Trial details

NCT number: NCT00130312
Sponsor: Keryx Biopharmaceuticals
Status: TERMINATED
Phase: Phase 4
Study type: INTERVENTIONAL

Diabetic Nephropathy

Start date: 2005-08-01
Primary completion: 2008-03-01
Enrollment: 968

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.